. Author manuscript; available in PMC: 2021 Oct 1.

Published in final edited form as: Am J Transplant. 2020 Apr 26;20(10):2768–2780. doi: 10.1111/ajt.15863

TABLE 3.

Multicenter cohort biopsy results (N = 546)

	n (%)
No rejection	298 (54.6)
Acute cell-mediated rejection (ACR) 1A	179 (32.8)
ACR 1B	50 (9.2)
ACR 2	11 (2.0)
ACR 3A	8 (1.5)
ACR 4	0 (0.0)
Antibody-mediated rejection	0 (0.0)^a
Mixed rejection	0 (0.0)

AMR was likely underreported in the multicenter cohort using the earlier 1990 ISHLT scoring²⁸ criteria.